Global Inhalation Sevoflurane Anaesthetic Agent Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Sevoflurane, also called fluoromethyl, is an ether inhalation anaesthetic agent used for the induction and maintenance of general anesthesia.
LPI (LP Information)' newest research report, the “Inhalation Sevoflurane Anaesthetic Agent Industry Forecast” looks at past sales and reviews total world Inhalation Sevoflurane Anaesthetic Agent sales in 2022, providing a comprehensive analysis by region and market sector of projected Inhalation Sevoflurane Anaesthetic Agent sales for 2023 through 2029. With Inhalation Sevoflurane Anaesthetic Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalation Sevoflurane Anaesthetic Agent industry.
This Insight Report provides a comprehensive analysis of the global Inhalation Sevoflurane Anaesthetic Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhalation Sevoflurane Anaesthetic Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Inhalation Sevoflurane Anaesthetic Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalation Sevoflurane Anaesthetic Agent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalation Sevoflurane Anaesthetic Agent.
The global Inhalation Sevoflurane Anaesthetic Agent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Inhalation Sevoflurane Anaesthetic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Inhalation Sevoflurane Anaesthetic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Inhalation Sevoflurane Anaesthetic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Inhalation Sevoflurane Anaesthetic Agent players cover AbbVie, Baxter, Maruishi Pharmaceutical, Jiangsu Hengrui and Lunan Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalation Sevoflurane Anaesthetic Agent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Inhalation Sevoflurane Anaesthetic Agent market?
What factors are driving Inhalation Sevoflurane Anaesthetic Agent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhalation Sevoflurane Anaesthetic Agent market opportunities vary by end market size?
How does Inhalation Sevoflurane Anaesthetic Agent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Sevoflurane, also called fluoromethyl, is an ether inhalation anaesthetic agent used for the induction and maintenance of general anesthesia.
LPI (LP Information)' newest research report, the “Inhalation Sevoflurane Anaesthetic Agent Industry Forecast” looks at past sales and reviews total world Inhalation Sevoflurane Anaesthetic Agent sales in 2022, providing a comprehensive analysis by region and market sector of projected Inhalation Sevoflurane Anaesthetic Agent sales for 2023 through 2029. With Inhalation Sevoflurane Anaesthetic Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalation Sevoflurane Anaesthetic Agent industry.
This Insight Report provides a comprehensive analysis of the global Inhalation Sevoflurane Anaesthetic Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhalation Sevoflurane Anaesthetic Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Inhalation Sevoflurane Anaesthetic Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalation Sevoflurane Anaesthetic Agent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalation Sevoflurane Anaesthetic Agent.
The global Inhalation Sevoflurane Anaesthetic Agent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Inhalation Sevoflurane Anaesthetic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Inhalation Sevoflurane Anaesthetic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Inhalation Sevoflurane Anaesthetic Agent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Inhalation Sevoflurane Anaesthetic Agent players cover AbbVie, Baxter, Maruishi Pharmaceutical, Jiangsu Hengrui and Lunan Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalation Sevoflurane Anaesthetic Agent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Generic Drug
- Brand Drug
- Chidren
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Baxter
- Maruishi Pharmaceutical
- Jiangsu Hengrui
- Lunan Pharmaceutical
What is the 10-year outlook for the global Inhalation Sevoflurane Anaesthetic Agent market?
What factors are driving Inhalation Sevoflurane Anaesthetic Agent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhalation Sevoflurane Anaesthetic Agent market opportunities vary by end market size?
How does Inhalation Sevoflurane Anaesthetic Agent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Inhalation Sevoflurane Anaesthetic Agent by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Inhalation Sevoflurane Anaesthetic Agent by Country/Region, 2018, 2022 & 2029
2.2 Inhalation Sevoflurane Anaesthetic Agent Segment by Type
2.2.1 Generic Drug
2.2.2 Brand Drug
2.3 Inhalation Sevoflurane Anaesthetic Agent Sales by Type
2.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
2.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue and Market Share by Type (2018-2023)
2.3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Type (2018-2023)
2.4 Inhalation Sevoflurane Anaesthetic Agent Segment by Application
2.4.1 Chidren
2.4.2 Adult
2.5 Inhalation Sevoflurane Anaesthetic Agent Sales by Application
2.5.1 Global Inhalation Sevoflurane Anaesthetic Agent Sale Market Share by Application (2018-2023)
2.5.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue and Market Share by Application (2018-2023)
2.5.3 Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Application (2018-2023)
3 GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT BY COMPANY
3.1 Global Inhalation Sevoflurane Anaesthetic Agent Breakdown Data by Company
3.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Annual Sales by Company (2018-2023)
3.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Company (2018-2023)
3.2 Global Inhalation Sevoflurane Anaesthetic Agent Annual Revenue by Company (2018-2023)
3.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Company (2018-2023)
3.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company (2018-2023)
3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Company
3.4 Key Manufacturers Inhalation Sevoflurane Anaesthetic Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhalation Sevoflurane Anaesthetic Agent Product Location Distribution
3.4.2 Players Inhalation Sevoflurane Anaesthetic Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INHALATION SEVOFLURANE ANAESTHETIC AGENT BY GEOGRAPHIC REGION
4.1 World Historic Inhalation Sevoflurane Anaesthetic Agent Market Size by Geographic Region (2018-2023)
4.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Inhalation Sevoflurane Anaesthetic Agent Market Size by Country/Region (2018-2023)
4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Annual Sales by Country/Region (2018-2023)
4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Annual Revenue by Country/Region (2018-2023)
4.3 Americas Inhalation Sevoflurane Anaesthetic Agent Sales Growth
4.4 APAC Inhalation Sevoflurane Anaesthetic Agent Sales Growth
4.5 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Growth
4.6 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Growth
5 AMERICAS
5.1 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Country
5.1.1 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023)
5.1.2 Americas Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023)
5.2 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Type
5.3 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Region
6.1.1 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2018-2023)
6.1.2 APAC Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2018-2023)
6.2 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Type
6.3 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inhalation Sevoflurane Anaesthetic Agent by Country
7.1.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023)
7.1.2 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023)
7.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type
7.3 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent by Country
8.1.1 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023)
8.1.2 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023)
8.2 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type
8.3 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhalation Sevoflurane Anaesthetic Agent
10.3 Manufacturing Process Analysis of Inhalation Sevoflurane Anaesthetic Agent
10.4 Industry Chain Structure of Inhalation Sevoflurane Anaesthetic Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhalation Sevoflurane Anaesthetic Agent Distributors
11.3 Inhalation Sevoflurane Anaesthetic Agent Customer
12 WORLD FORECAST REVIEW FOR INHALATION SEVOFLURANE ANAESTHETIC AGENT BY GEOGRAPHIC REGION
12.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Region
12.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Forecast by Region (2024-2029)
12.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inhalation Sevoflurane Anaesthetic Agent Forecast by Type
12.7 Global Inhalation Sevoflurane Anaesthetic Agent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
13.1.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
13.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Maruishi Pharmaceutical
13.3.1 Maruishi Pharmaceutical Company Information
13.3.2 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
13.3.3 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Maruishi Pharmaceutical Main Business Overview
13.3.5 Maruishi Pharmaceutical Latest Developments
13.4 Jiangsu Hengrui
13.4.1 Jiangsu Hengrui Company Information
13.4.2 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
13.4.3 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Jiangsu Hengrui Main Business Overview
13.4.5 Jiangsu Hengrui Latest Developments
13.5 Lunan Pharmaceutical
13.5.1 Lunan Pharmaceutical Company Information
13.5.2 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
13.5.3 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lunan Pharmaceutical Main Business Overview
13.5.5 Lunan Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Inhalation Sevoflurane Anaesthetic Agent by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Inhalation Sevoflurane Anaesthetic Agent by Country/Region, 2018, 2022 & 2029
2.2 Inhalation Sevoflurane Anaesthetic Agent Segment by Type
2.2.1 Generic Drug
2.2.2 Brand Drug
2.3 Inhalation Sevoflurane Anaesthetic Agent Sales by Type
2.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
2.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue and Market Share by Type (2018-2023)
2.3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Type (2018-2023)
2.4 Inhalation Sevoflurane Anaesthetic Agent Segment by Application
2.4.1 Chidren
2.4.2 Adult
2.5 Inhalation Sevoflurane Anaesthetic Agent Sales by Application
2.5.1 Global Inhalation Sevoflurane Anaesthetic Agent Sale Market Share by Application (2018-2023)
2.5.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue and Market Share by Application (2018-2023)
2.5.3 Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Application (2018-2023)
3 GLOBAL INHALATION SEVOFLURANE ANAESTHETIC AGENT BY COMPANY
3.1 Global Inhalation Sevoflurane Anaesthetic Agent Breakdown Data by Company
3.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Annual Sales by Company (2018-2023)
3.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Company (2018-2023)
3.2 Global Inhalation Sevoflurane Anaesthetic Agent Annual Revenue by Company (2018-2023)
3.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Company (2018-2023)
3.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company (2018-2023)
3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Company
3.4 Key Manufacturers Inhalation Sevoflurane Anaesthetic Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhalation Sevoflurane Anaesthetic Agent Product Location Distribution
3.4.2 Players Inhalation Sevoflurane Anaesthetic Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INHALATION SEVOFLURANE ANAESTHETIC AGENT BY GEOGRAPHIC REGION
4.1 World Historic Inhalation Sevoflurane Anaesthetic Agent Market Size by Geographic Region (2018-2023)
4.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Inhalation Sevoflurane Anaesthetic Agent Market Size by Country/Region (2018-2023)
4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Annual Sales by Country/Region (2018-2023)
4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Annual Revenue by Country/Region (2018-2023)
4.3 Americas Inhalation Sevoflurane Anaesthetic Agent Sales Growth
4.4 APAC Inhalation Sevoflurane Anaesthetic Agent Sales Growth
4.5 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Growth
4.6 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Growth
5 AMERICAS
5.1 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Country
5.1.1 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023)
5.1.2 Americas Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023)
5.2 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Type
5.3 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Region
6.1.1 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2018-2023)
6.1.2 APAC Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2018-2023)
6.2 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Type
6.3 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inhalation Sevoflurane Anaesthetic Agent by Country
7.1.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023)
7.1.2 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023)
7.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type
7.3 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent by Country
8.1.1 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023)
8.1.2 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023)
8.2 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type
8.3 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhalation Sevoflurane Anaesthetic Agent
10.3 Manufacturing Process Analysis of Inhalation Sevoflurane Anaesthetic Agent
10.4 Industry Chain Structure of Inhalation Sevoflurane Anaesthetic Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhalation Sevoflurane Anaesthetic Agent Distributors
11.3 Inhalation Sevoflurane Anaesthetic Agent Customer
12 WORLD FORECAST REVIEW FOR INHALATION SEVOFLURANE ANAESTHETIC AGENT BY GEOGRAPHIC REGION
12.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast by Region
12.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Forecast by Region (2024-2029)
12.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inhalation Sevoflurane Anaesthetic Agent Forecast by Type
12.7 Global Inhalation Sevoflurane Anaesthetic Agent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
13.1.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
13.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Maruishi Pharmaceutical
13.3.1 Maruishi Pharmaceutical Company Information
13.3.2 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
13.3.3 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Maruishi Pharmaceutical Main Business Overview
13.3.5 Maruishi Pharmaceutical Latest Developments
13.4 Jiangsu Hengrui
13.4.1 Jiangsu Hengrui Company Information
13.4.2 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
13.4.3 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Jiangsu Hengrui Main Business Overview
13.4.5 Jiangsu Hengrui Latest Developments
13.5 Lunan Pharmaceutical
13.5.1 Lunan Pharmaceutical Company Information
13.5.2 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
13.5.3 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lunan Pharmaceutical Main Business Overview
13.5.5 Lunan Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Inhalation Sevoflurane Anaesthetic Agent Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Inhalation Sevoflurane Anaesthetic Agent Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Generic Drug
Table 4. Major Players of Brand Drug
Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023) & (K Units)
Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2018-2023) & ($ million)
Table 8. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2018-2023)
Table 9. Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023) & (K Units)
Table 11. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Table 12. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2018-2023)
Table 13. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2018-2023)
Table 14. Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Company (2018-2023) & (K Units)
Table 16. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Company (2018-2023)
Table 17. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company (2018-2023)
Table 19. Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Inhalation Sevoflurane Anaesthetic Agent Producing Area Distribution and Sales Area
Table 21. Players Inhalation Sevoflurane Anaesthetic Agent Products Offered
Table 22. Inhalation Sevoflurane Anaesthetic Agent Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Geographic Region (2018-2023)
Table 27. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country/Region (2018-2023)
Table 31. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 34. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2023)
Table 35. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2023)
Table 37. Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023) & (K Units)
Table 38. Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023) & (K Units)
Table 39. APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2018-2023) & (K Units)
Table 40. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2018-2023)
Table 41. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2018-2023)
Table 43. APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023) & (K Units)
Table 44. APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023) & (K Units)
Table 45. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 46. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2023)
Table 47. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2023)
Table 49. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023) & (K Units)
Table 50. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Inhalation Sevoflurane Anaesthetic Agent
Table 58. Key Market Challenges & Risks of Inhalation Sevoflurane Anaesthetic Agent
Table 59. Key Industry Trends of Inhalation Sevoflurane Anaesthetic Agent
Table 60. Inhalation Sevoflurane Anaesthetic Agent Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Inhalation Sevoflurane Anaesthetic Agent Distributors List
Table 63. Inhalation Sevoflurane Anaesthetic Agent Customer List
Table 64. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AbbVie Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors
Table 79. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
Table 80. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. AbbVie Main Business
Table 82. AbbVie Latest Developments
Table 83. Baxter Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors
Table 84. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
Table 85. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Baxter Main Business
Table 87. Baxter Latest Developments
Table 88. Maruishi Pharmaceutical Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors
Table 89. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
Table 90. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Maruishi Pharmaceutical Main Business
Table 92. Maruishi Pharmaceutical Latest Developments
Table 93. Jiangsu Hengrui Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors
Table 94. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
Table 95. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Jiangsu Hengrui Main Business
Table 97. Jiangsu Hengrui Latest Developments
Table 98. Lunan Pharmaceutical Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors
Table 99. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
Table 100. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Lunan Pharmaceutical Main Business
Table 102. Lunan Pharmaceutical Latest Developments
Table 1. Inhalation Sevoflurane Anaesthetic Agent Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Inhalation Sevoflurane Anaesthetic Agent Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Generic Drug
Table 4. Major Players of Brand Drug
Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023) & (K Units)
Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2018-2023) & ($ million)
Table 8. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2018-2023)
Table 9. Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023) & (K Units)
Table 11. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Table 12. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2018-2023)
Table 13. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2018-2023)
Table 14. Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Company (2018-2023) & (K Units)
Table 16. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Company (2018-2023)
Table 17. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company (2018-2023)
Table 19. Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Inhalation Sevoflurane Anaesthetic Agent Producing Area Distribution and Sales Area
Table 21. Players Inhalation Sevoflurane Anaesthetic Agent Products Offered
Table 22. Inhalation Sevoflurane Anaesthetic Agent Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Geographic Region (2018-2023)
Table 27. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country/Region (2018-2023)
Table 31. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 34. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2023)
Table 35. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2023)
Table 37. Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023) & (K Units)
Table 38. Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023) & (K Units)
Table 39. APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2018-2023) & (K Units)
Table 40. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2018-2023)
Table 41. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2018-2023)
Table 43. APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023) & (K Units)
Table 44. APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023) & (K Units)
Table 45. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 46. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2023)
Table 47. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2023)
Table 49. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023) & (K Units)
Table 50. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Inhalation Sevoflurane Anaesthetic Agent
Table 58. Key Market Challenges & Risks of Inhalation Sevoflurane Anaesthetic Agent
Table 59. Key Industry Trends of Inhalation Sevoflurane Anaesthetic Agent
Table 60. Inhalation Sevoflurane Anaesthetic Agent Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Inhalation Sevoflurane Anaesthetic Agent Distributors List
Table 63. Inhalation Sevoflurane Anaesthetic Agent Customer List
Table 64. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AbbVie Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors
Table 79. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
Table 80. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. AbbVie Main Business
Table 82. AbbVie Latest Developments
Table 83. Baxter Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors
Table 84. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
Table 85. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Baxter Main Business
Table 87. Baxter Latest Developments
Table 88. Maruishi Pharmaceutical Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors
Table 89. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
Table 90. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Maruishi Pharmaceutical Main Business
Table 92. Maruishi Pharmaceutical Latest Developments
Table 93. Jiangsu Hengrui Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors
Table 94. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
Table 95. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Jiangsu Hengrui Main Business
Table 97. Jiangsu Hengrui Latest Developments
Table 98. Lunan Pharmaceutical Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors
Table 99. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolios and Specifications
Table 100. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Lunan Pharmaceutical Main Business
Table 102. Lunan Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Inhalation Sevoflurane Anaesthetic Agent
Figure 2. Inhalation Sevoflurane Anaesthetic Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Generic Drug
Figure 10. Product Picture of Brand Drug
Figure 11. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type in 2022
Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2018-2023)
Figure 13. Inhalation Sevoflurane Anaesthetic Agent Consumed in Chidren
Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Market: Chidren (2018-2023) & (K Units)
Figure 15. Inhalation Sevoflurane Anaesthetic Agent Consumed in Adult
Figure 16. Global Inhalation Sevoflurane Anaesthetic Agent Market: Adult (2018-2023) & (K Units)
Figure 17. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2022)
Figure 18. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application in 2022
Figure 19. Inhalation Sevoflurane Anaesthetic Agent Sales Market by Company in 2022 (K Units)
Figure 20. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Company in 2022
Figure 21. Inhalation Sevoflurane Anaesthetic Agent Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company in 2022
Figure 23. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Inhalation Sevoflurane Anaesthetic Agent Sales 2018-2023 (K Units)
Figure 26. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue 2018-2023 ($ Millions)
Figure 27. APAC Inhalation Sevoflurane Anaesthetic Agent Sales 2018-2023 (K Units)
Figure 28. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue 2018-2023 ($ Millions)
Figure 29. Europe Inhalation Sevoflurane Anaesthetic Agent Sales 2018-2023 (K Units)
Figure 30. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue 2018-2023 ($ Millions)
Figure 33. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2022
Figure 34. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country in 2022
Figure 35. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Figure 36. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Figure 37. United States Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region in 2022
Figure 42. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Regions in 2022
Figure 43. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Figure 44. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Figure 45. China Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2022
Figure 53. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country in 2022
Figure 54. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Figure 55. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Figure 56. Germany Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Figure 65. Egypt Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Inhalation Sevoflurane Anaesthetic Agent in 2022
Figure 71. Manufacturing Process Analysis of Inhalation Sevoflurane Anaesthetic Agent
Figure 72. Industry Chain Structure of Inhalation Sevoflurane Anaesthetic Agent
Figure 73. Channels of Distribution
Figure 74. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Forecast by Region (2024-2029)
Figure 75. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Inhalation Sevoflurane Anaesthetic Agent
Figure 2. Inhalation Sevoflurane Anaesthetic Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Generic Drug
Figure 10. Product Picture of Brand Drug
Figure 11. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type in 2022
Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2018-2023)
Figure 13. Inhalation Sevoflurane Anaesthetic Agent Consumed in Chidren
Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Market: Chidren (2018-2023) & (K Units)
Figure 15. Inhalation Sevoflurane Anaesthetic Agent Consumed in Adult
Figure 16. Global Inhalation Sevoflurane Anaesthetic Agent Market: Adult (2018-2023) & (K Units)
Figure 17. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2022)
Figure 18. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application in 2022
Figure 19. Inhalation Sevoflurane Anaesthetic Agent Sales Market by Company in 2022 (K Units)
Figure 20. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Company in 2022
Figure 21. Inhalation Sevoflurane Anaesthetic Agent Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company in 2022
Figure 23. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Inhalation Sevoflurane Anaesthetic Agent Sales 2018-2023 (K Units)
Figure 26. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue 2018-2023 ($ Millions)
Figure 27. APAC Inhalation Sevoflurane Anaesthetic Agent Sales 2018-2023 (K Units)
Figure 28. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue 2018-2023 ($ Millions)
Figure 29. Europe Inhalation Sevoflurane Anaesthetic Agent Sales 2018-2023 (K Units)
Figure 30. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue 2018-2023 ($ Millions)
Figure 33. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2022
Figure 34. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country in 2022
Figure 35. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Figure 36. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Figure 37. United States Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region in 2022
Figure 42. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Regions in 2022
Figure 43. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Figure 44. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Figure 45. China Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2022
Figure 53. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country in 2022
Figure 54. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Figure 55. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Figure 56. Germany Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2018-2023)
Figure 65. Egypt Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Inhalation Sevoflurane Anaesthetic Agent in 2022
Figure 71. Manufacturing Process Analysis of Inhalation Sevoflurane Anaesthetic Agent
Figure 72. Industry Chain Structure of Inhalation Sevoflurane Anaesthetic Agent
Figure 73. Channels of Distribution
Figure 74. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Forecast by Region (2024-2029)
Figure 75. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share Forecast by Application (2024-2029)
